Emerging from the UK, retatrutide, a novel peptide , is sparking considerable buzz within the medical community regarding its potential for body management . This dual GIP and GLP-1 receptor agonist seems to offer a considerable improvement over current therapies, showing positive results in early clinical trials . Researchers believe its distincti